Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AtriCure Q4 2023 Adj EPS $(0.21) Beats $(0.23) Estimate, Sales $106.50M Beat $103.68M Estimate

Author: Benzinga Newsdesk | February 15, 2024 05:03pm
AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.23) by 8.7 percent. The company reported quarterly sales of $106.50 million which beat the analyst consensus estimate of $103.68 million by 2.72 percent. This is a 20.98 percent increase over sales of $88.03 million the same period last year.

Posted In: ATRC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist